JUNSHI BIO(01877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01877 JUNSHI BIO

Trading 03-27 10:02:47

21.820

+0.620

+2.92%

High21.820	Low20.880	Vol407.20K
Open20.940	D1 Closing21.200	Amplitude4.43%
Mkt Cap22.41B	Tradable Cap5.67B	Total Shares1.03B
T/O8.74M	T/O Rate0.16%	Tradable Shares260.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"JUNSHI BIO","latestPrice":21.82,"timestamp":1774576965788,"preClose":21.2,"halted":0,"volume":407200,"delay":0,"changeRate":0.029245283018867974,"floatShares":260000000,"shares":1027000000,"eps":-0.87,"marketStatus":"Trading","change":0.62,"latestTime":"03-27 10:02:47","open":20.94,"high":21.82,"low":20.88,"amount":8741656,"amplitude":0.04434,"askPrice":21.84,"askSize":3000,"bidPrice":21.8,"bidSize":1800,"shortable":3,"etf":0,"ttmEps":-0.907,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1774584000000},"marketStatusCode":2,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":21.2,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"volumeRatio":1.255689,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"Shanghai Junshi Biosciences Co.,Ltd.","latestPrice":33.23,"timestamp":1774576963000,"preClose":32.46,"halted":0,"volume":3785000,"delay":0,"premium":"-41.98"}},"requestUrl":"/m/hq/s/01877/tweets","defaultTab":"tweets","newsList":[{"id":"1193725047","title":"JUNSHI BIO Sees 28% Revenue Growth, Yet Struggles to Close Nearly 10-Billion-Yuan Loss Gap","url":"https://stock-news.laohu8.com/highlight/detail?id=1193725047","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193725047?lang=en_us&edition=fundamental","pubTime":"2026-03-25 14:41","pubTimestamp":1774420870,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co.,Ltd. (JUNSHI BIO, stock codes: 688180.SH / 01877.HK) recently released its 2025 annual report. The company achieved annual operating revenue of 2.498 billion yuan, a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1515","688180","BK1161","BK0239","01877"],"gpt_icon":0},{"id":"2621144797","title":"Is It Time To Reassess Shanghai Junshi Biosciences (SEHK:1877) After Its Recent Share Price Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2621144797","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621144797?lang=en_us&edition=fundamental","pubTime":"2026-03-22 08:22","pubTimestamp":1774138973,"startTime":"0","endTime":"0","summary":"If you are wondering whether Shanghai Junshi Biosciences at HK$21.90 still offers value after a strong run, this breakdown will help you frame the opportunity and the risks in a structured way.\nThe stock has returned 9.2% over the past week and 4.5% over the last 30 days, with a 51.0% return over the past year but a 1.7% decline year to date and deeper losses over 3 and 5 years. These mixed figures may leave you questioning whether the recent strength signals a shift in sentiment or just...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/is-it-time-to-reassess-shanghai-junshi-biosciences-sehk1877","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/is-it-time-to-reassess-shanghai-junshi-biosciences-sehk1877","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1161","BK1515","01877","DCF"],"gpt_icon":0},{"id":"1111826406","title":"Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1111826406","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111826406?lang=en_us&edition=fundamental","pubTime":"2026-03-20 18:23","pubTimestamp":1774002196,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"gpt_icon":0},{"id":"1151911837","title":"Stock Track | Junshi Biosciences Soars 5.04% Intraday as Chairman Increases Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=1151911837","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151911837?lang=en_us&edition=fundamental","pubTime":"2026-03-17 10:19","pubTimestamp":1773713947,"startTime":"0","endTime":"0","summary":"Junshi Biosciences' stock soared 5.04% during Tuesday's morning trading session following news of increased insider confidence in the company.The surge came after the company's chairman, Xiong Jun,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01877"],"gpt_icon":0},{"id":"2620419965","title":"Junshi Biosciences' Chairman Raises Stake for 12 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2620419965","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620419965?lang=en_us&edition=fundamental","pubTime":"2026-03-17 09:46","pubTimestamp":1773712011,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences'  chairman, Xiong Jun, raised his shareholding for 12.2 million yuan, according to a Hong Kong filing on Monday.The pharmaceutical company's Shanghai shares rose over 2% in Tuesday's morning trade.Xiong acquired an additional 365,382 shares, or 0.04% of the company's total share capital.The move is part of Xiong's plan to increase his stake by 50 million yuan to 100 million yuan. The share increase transaction is still ongoing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK0239","BK1161","01877","BK1515","688180"],"gpt_icon":0},{"id":"2619299463","title":"BRIEF-Shanghai Junshi Biosciences Says As At Mar 16, Controlling Shareholder Increased A Shares By 365,382 Shares For Total RMB12.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2619299463","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619299463?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:54","pubTimestamp":1773665661,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Junshi Biosciences Says As At Mar 16, Controlling Shareholder Increased A Shares By 365,382 Shares For Total RMB12.2 MlnMarch 16  - Shanghai Junshi Biosciences Co Ltd 688180.SS:AS AT MAR 16, CONTROLLING SHAREHOLDER INCREASED SHAREHOLDINGS OF A SHARES BY 365,382 SHARES FOR TOTAL RMB12.2 MILLIONFurther company coverage: 688180.SS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN404076:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","BK0239","BK1583","688180","01877"],"gpt_icon":0},{"id":"1110990003","title":"JUNSHI BIO Chairman Xiong Jun Increases Holdings by 365,400 A-Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1110990003","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110990003?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:32","pubTimestamp":1773664356,"startTime":"0","endTime":"0","summary":"JUNSHI BIO (01877) announced that Mr. Xiong Jun, a controlling shareholder, one of the actual controllers, and Chairman of the Board of Shanghai Junshi Biosciences Co., Ltd., plans to increase his...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1161","399300","159982","BK1583","688180","BK1515","01877"],"gpt_icon":0},{"id":"1198680700","title":"JUNSHI BIO Reports 28.23% Revenue Increase to RMB 2.5 Billion for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1198680700","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198680700?lang=en_us&edition=fundamental","pubTime":"2026-03-16 14:01","pubTimestamp":1773640864,"startTime":"0","endTime":"0","summary":"JUNSHI BIO recently announced its financial results for 2025. The company achieved operating revenue of RMB 2.498 billion, representing a year-on-year increase of 28.23%. However, the net profit...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK0239","688180","BK1583","01877","BK1161"],"gpt_icon":0},{"id":"2619289104","title":"Shanghai Junshi Biosciences SEHK 1877 Valuation After Mixed Recent Share Performance And DCF Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2619289104","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619289104?lang=en_us&edition=fundamental","pubTime":"2026-03-15 21:22","pubTimestamp":1773580972,"startTime":"0","endTime":"0","summary":"Context for Shanghai Junshi Biosciences after recent share performance\nShanghai Junshi Biosciences (SEHK:1877) has seen mixed share performance recently, with a small gain over the past week but declines over the past month and past 3 months, drawing attention to how its fundamentals line up.\nFor investors tracking the stock longer term, the shares show a negative total return over 3 and 5 years, while the 1 year total return is positive. This can make current pricing and expectations...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/shanghai-junshi-biosciences-sehk-1877-valuation-after-mixed","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/shanghai-junshi-biosciences-sehk-1877-valuation-after-mixed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01877","BK1583","BK1515","DCF","BK1161"],"gpt_icon":0},{"id":"2619118112","title":"Press Release: Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2619118112","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619118112?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:54","pubTimestamp":1773410040,"startTime":"0","endTime":"0","summary":"SHANGHAI, March 13, 2026  -- Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2025 and provided corporate updates.-- Total revenue of Junshi Biosciences was approximately RMB2,498 million in. 2025, representing an increase of approximately 28% compared to 2024,which was mainly due to the increase in revenue from sales of. pharmaceutical products, in particular the domestic sales revenue of the. company's core product, toripalimab, was approximately RMB2,068 million,representing an increase of approximately 38% compared to 2024.-- Total research and development  expenses of the company were. approximately RMB1,384 million in 2025, representing an increase of. approximately 9% compared to 2024. The increase in R&D expenses was. mainly due to the company's focus on more competitive and innovative R&D. During 202","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4231","01877","BK1515","ADC","BK4080","BK1583"],"gpt_icon":0},{"id":"1172458825","title":"Junshi Bio (01877) posts RMB0.88 billion 2025 loss, skips dividend, sets RMB5.00 billion guarantee cap and taps up to RMB1.50 billion idle proceeds for liquidity","url":"https://stock-news.laohu8.com/highlight/detail?id=1172458825","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172458825?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:41","pubTimestamp":1773409317,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877.HK; 688180.SH) released a series of board resolutions and regulatory filings dated 13–14 March 2026 that outline its 2025 results, capital-use...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"gpt_icon":0},{"id":"1185129771","title":"JUNSHI BIO Revamps Board Committee to Include ESG Oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=1185129771","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185129771?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:04","pubTimestamp":1773403468,"startTime":"0","endTime":"0","summary":"JUNSHI BIO (01877) has announced that its board of directors has passed a resolution to reconfigure the existing Strategy Committee into a Strategy and ESG Committee, effective March 13, 2026. This...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688180","BK1161","BK1515","ESG","BK1583","159717","BK0239","01877"],"gpt_icon":0},{"id":"1174834365","title":"Junshi Bio (01877) Announces Updated Board Composition and Committee Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=1174834365","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174834365?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:01","pubTimestamp":1773403273,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) released an updated list of directors and their committee appointments dated 13 March 2026. The Board now comprises:   • 8 executive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"gpt_icon":0},{"id":"1177993856","title":"Junshi Bio (01877) Elevates Strategic Focus with New ESG Mandate and Drafts Director & Executive Pay Policies","url":"https://stock-news.laohu8.com/highlight/detail?id=1177993856","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177993856?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:00","pubTimestamp":1773403254,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) has restructured its board-level Strategic Committee into a “Strategic and ESG Committee”, effective 13 March 2026, to integrate...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"gpt_icon":0},{"id":"2619153246","title":"BRIEF-Shanghai Junshi Biosciences Says Resolution On Temporary Replenishment Of Liquidity Approved","url":"https://stock-news.laohu8.com/highlight/detail?id=2619153246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619153246?lang=en_us&edition=fundamental","pubTime":"2026-03-13 00:57","pubTimestamp":1773334674,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Junshi Biosciences Says Resolution On Temporary Replenishment Of Liquidity ApprovedMarch 12 (Reuters) - Shanghai Junshi Biosciences Co Ltd 688180.SS:RESOLUTION ON TEMPORARY REPLENISHMEN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01877","688180","BK0239","BK1515","BK1161"],"gpt_icon":0},{"id":"1179340994","title":"Junshi Bio (01877) Fully Returns RMB1.11 Billion of Idle Proceeds Previously Deployed for Working-Capital Needs","url":"https://stock-news.laohu8.com/highlight/detail?id=1179340994","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179340994?lang=en_us&edition=fundamental","pubTime":"2026-03-12 19:42","pubTimestamp":1773315771,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, HKEX: 01877; SSE: 688180) has announced the complete return of RMB1.11 billion in idle IPO proceeds that had been temporarily allocated to bolster...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"gpt_icon":0},{"id":"2618396751","title":"Shanghai Junshi Biosciences - Proceeds Would Only Be Used for Business Expansion, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2618396751","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618396751?lang=en_us&edition=fundamental","pubTime":"2026-03-12 19:27","pubTimestamp":1773314878,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000VV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1583","BK1515","688180","BK0239","01877"],"gpt_icon":0},{"id":"2618139622","title":"Shanghai Junshi Biosciences - Resolution on Temporary Replenishment of Liquidity Approved to Use Idle Proceeds of No More Than RMB2 Bln (Inclusive)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618139622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618139622?lang=en_us&edition=fundamental","pubTime":"2026-03-12 19:27","pubTimestamp":1773314878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01877","BK1515","688180","BK0239","BK1161","BK1583"],"gpt_icon":0},{"id":"1174407842","title":"Junshi Biosciences Excluded from STAR 50 Index as Revenue Growth Fails to Reverse Loss Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1174407842","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174407842?lang=en_us&edition=fundamental","pubTime":"2026-03-12 16:42","pubTimestamp":1773304954,"startTime":"0","endTime":"0","summary":"On March 13, the adjustment of the STAR 50 index constituents will take effect. Junshi Biosciences (688180.SH), once a leading PD-1 developer among the \"four small dragons\" in the innovative drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","688180","BK1161","BK1515","BK1583","BK0239"],"gpt_icon":0},{"id":"2618570799","title":"BRIEF-Shanghai Junshi Biosciences Says Chairman Intended To Increase Shareholding In Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2618570799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618570799?lang=en_us&edition=fundamental","pubTime":"2026-03-11 01:10","pubTimestamp":1773162645,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Junshi Biosciences Says Chairman Intended To Increase Shareholding In CoMarch 10  - Shanghai Junshi Biosciences Co Ltd 688180.SS:CHAIRMAN INTENDED TO INCREASE SHAREHOLDING IN BOTH A SHARES & H SHARES OF CO FOR NOT LESS THAN RMB100 MILLIONFurther company coverage: 688180.SS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY0LE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","BK1583","BK1515","BK1161","688180","BK0239"],"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":-0.0257},{"period":"1month","weight":0.0086},{"period":"3month","weight":-0.0603},{"period":"6month","weight":-0.2891},{"period":"1year","weight":0.5186},{"period":"ytd","weight":-0.0066}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":-0.0652},{"period":"3month","weight":-0.0373},{"period":"6month","weight":-0.0487},{"period":"1year","weight":0.0585},{"period":"ytd","weight":-0.0302}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Junshi Biosciences Co Ltd is a China-based company mainly engaged in innovation-driven biopharmaceutical business. The Company's main businesses are the discovery, clinical research and development of innovative drugs. The Company's main products include teriprizumab injection, Etesevimab, adalimumab injection and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases and infectious diseases. The Company is also engaged in the clinical research and development of recombinant humanized anti-PCSK9 monoclonal antibody injection and other drugs. The Company provides its products for domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.062525},{"month":3,"riseRate":0.75,"avgChangeRate":0.04738},{"month":4,"riseRate":0.857143,"avgChangeRate":0.101581},{"month":5,"riseRate":0.428571,"avgChangeRate":0.004505},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.018268},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.014588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"JUNSHI BIO","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"JUNSHI BIO(01877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest JUNSHI BIO(01877) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"JUNSHI BIO,01877,JUNSHI BIO股票,JUNSHI BIO股票老虎,JUNSHI BIO股票老虎国际,JUNSHI BIO行情,JUNSHI BIO股票行情,JUNSHI BIO股价,JUNSHI BIO股市,JUNSHI BIO股票价格,JUNSHI BIO股票交易,JUNSHI BIO股票购买,JUNSHI BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"JUNSHI BIO(01877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest JUNSHI BIO(01877) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}